ANI Pharmaceuticals, Inc. (ANIP) — Business segments and KPIs
Revenue by business segment and geography for ANI Pharmaceuticals, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Sales of rare disease pharmaceutical products | 422.65M | 47.8% |
| Total Sales of Generics and Other | 399.41M | 45.2% |
| Sales of Established Brands | 61.31M | 6.9% |
| Revenue by region | ||
| UNITED STATES | 852.44M | 96.5% |
| Non-US | 30.92M | 3.5% |